cyclandelate has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Cyclandelate: A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
cyclandelate : The ester obtained by formal condensation of mandelic acid and 3,3,5-tricyclohexanol. It is a direct-acting smooth muscle relaxant used to dilate blood vessels.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous trials have demonstrated a clinical and electrophysiological improvement of diabetic peripheral polyneuropathy in diabetic patients treated with cyclandelate at a dosage of 1600 mg/day." | 2.66 | Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy. ( De Leeuw, IH; Driessens, M; Moeremans, M; Van Rooy, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Leeuw, IH | 1 |
| Van Rooy, P | 1 |
| Moeremans, M | 1 |
| Driessens, M | 1 |
1 trial available for cyclandelate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.
Topics: Adult; Aged; Auditory Threshold; Clinical Trials as Topic; Cyclandelate; Diabetes Mellitus, Type 1; | 1987 |